Condensed Consolidated Statements of Operations and Comprehensive Loss - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Income Statement [Abstract]
Net revenue	$ 14,436	$ 10,117	$ 41,690	$ 33,281
Net operating costs and expenses:
Cost of revenue	3,768	3,392	11,998	11,160
Research and development	2,349	4,072	7,461	10,012
Selling, general and administrative	29,734	40,431	83,610	96,121
Intangible amortization	1,002	1,027	3,030	3,080
Legal settlements	(2,500)	0	(9,391)	0
Total net operating costs and expenses	34,353	48,922	96,708	120,373
Loss from operations	(19,917)	(38,805)	(55,018)	(87,092)
Other (income) expense, net:
(Gain) loss on derivative liability	(18,108)	(4,245)	(2,367)	1,090
Change in fair value of debt and liability instruments	1,957	449	11,961	4,197
Interest expense, net	576	513	1,678	517
Loss on foreign currency exchange	46	7	57	30
Total other (income) expense, net	(15,529)	(3,276)	11,329	5,834
Loss before income taxes	(4,388)	(35,529)	(66,347)	(92,926)
Income tax expense	0	0	0	5
Net loss	$ (4,388)	$ (35,529)	$ (66,347)	$ (92,931)
Net loss per share attributable to common stockholders - basic and diluted
Net loss per share attributable to common stockholders - basic	$ (0.03)	$ (0.63)	$ (0.56)	$ (1.03)
Net loss per share attributable to common stockholders - diluted	$ (0.03)	$ (0.63)	$ (0.56)	$ (1.03)
Weighted average number of shares during the period - basic and diluted
Weighted average number of shares during the period-basic	126,964	139,808	118,566	141,358
Weighted average number of shares during the period -diluted	126,964	139,808	118,566	141,358
Comprehensive loss:
Net Income (Loss)	$ (4,388)	$ (35,529)	$ (66,347)	$ (92,931)
Other comprehensive income:
Changes in fair value attributable to instrument-specific credit risk	3,160	0	5,011	0
Total other comprehensive income	3,160	0	5,011	0
Comprehensive loss	$ (1,228)	$ (35,529)	$ (61,336)	$ (92,931)